Drug Topics Advisory Board member Phil Burgess has been appointed to the American Pharmacists Association (APhA) Health Information Technology Advisory Panel.
Drug Topics
Advisory Board member Philip Burgess has been appointed to the American Pharmacists Association (APhA) Health Information Technology Advisory Panel.
How Differences in Bispecific Therapies Impact Myeloma Treatment Operations
April 18th 2024According to Kirollos Hanna, PharmD, although similarities exist between bispecific therapies in the myeloma space, health care providers should take special note of practical differences and nuances associated with each when operationalizing them at their site of care.